当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:36.45亿  总市值:44.20亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,058,450,186.963,352,339,818.761,878,730,359.987,105,883,164.86
收到的税费返还99,666,812.7299,609,472.9261,114,695.46114,840,153.73
收到其他与经营活动有关的现金158,577,895.5152,672,744.2727,453,205.89200,850,679.41
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,316,694,895.193,504,622,035.951,967,298,261.337,421,573,998
购买商品、接受劳务支付的现金3,296,300,133.062,202,749,271.811,599,602,962.867,485,391,728.3
支付给职工以及为职工支付的现金189,378,670.95127,419,162.7968,676,421.15264,143,586.66
支付的各项税费90,508,447.6766,336,818.3349,034,304.37124,288,931.97
支付其他与经营活动有关的现金137,321,034.4175,032,754.1252,553,049.1136,218,923.76
经营活动现金流出的平衡项目0000
经营活动现金流出小计3,713,508,286.092,471,538,007.051,769,866,737.488,010,043,170.69
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,603,186,609.11,033,084,028.9197,431,523.85-588,469,172.69
二、投资活动产生的现金流量:
收回投资收到的现金1,155,980,563.47888,291,807.47648,538,819118,863,442.35
取得投资收益收到的现金10,788,235.6413,232,282.2215,080,727.3577,561,964.65
处置固定资产、无形资产和其他长期资产收回的现金净额94,149.5394,149.53-283,823.87
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,166,862,948.64901,618,239.22663,619,546.35196,709,230.87
购建固定资产、无形资产和其他长期资产支付的现金149,980,402.6483,394,374.3634,050,563.38189,199,325.79
投资支付的现金801,677,762.46548,175,676.63157,434,766.6455,777,428.21
投资活动现金流出的平衡项目0000
投资活动现金流出小计951,658,165.1631,570,050.99191,485,329.98644,976,754
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额215,204,783.54270,048,188.23472,134,216.37-448,267,523.13
三、筹资活动产生的现金流量:
取得借款收到的现金3,448,038,020.22,887,838,020.21,453,585,020.24,677,667,378.7
收到其他与筹资活动有关的现金220,000,000-1,970,000498,939,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计3,668,038,020.22,887,838,020.21,455,555,020.25,176,606,378.7
偿还债务支付的现金3,643,082,9692,578,917,000812,000,0003,379,969,305.56
分配股利、利润或偿付利息支付的现金152,004,899.95129,278,342.9529,373,479.56181,414,538.38
其中:子公司支付给少数股东的股利、利润793,517.8793,517.8--
支付其他与筹资活动有关的现金444,515,155.91321,849,396.36148,021,065.24318,406,134
筹资活动现金流出平衡项目0000
筹资活动现金流出小计4,239,603,024.863,030,044,739.31989,394,544.83,879,789,977.94
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-571,565,004.66-142,206,719.11466,160,475.41,296,816,400.76
四、汇率变动对现金及现金等价物的影响-6,716,726.56-4,916,168.61-2,405,269.04-6,050,321.18
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,240,109,661.421,156,009,329.411,133,320,946.58254,029,383.76
加:期初现金及现金等价物余额1,085,264,962.721,085,264,962.721,085,264,962.72831,235,578.96
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,325,374,624.142,241,274,292.132,218,585,909.31,085,264,962.72
补充资料:
净利润-93,790,702.64-494,173,306.76
资产减值准备-2,369,527.74--4,056,267.83
固定资产和投资性房地产折旧-78,680,188.34-144,428,199.51
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-78,680,188.34-144,428,199.51
无形资产摊销-7,856,874.98-8,115,719.32
长期待摊费用摊销-100,000.02-200,000.04
处置固定资产、无形资产和其他长期资产的损失---632,753
固定资产报废损失-202,988.68-1,102,030.14
公允价值变动损失-6,447,474.73--5,363,332.98
财务费用-65,144,695.63-70,091,151.09
投资损失--15,988,000.75--68,655,795.66
递延所得税-2,483,724.93--8,603,640.79
其中:递延所得税资产减少-2,623,242.89--8,601,758.19
递延所得税负债增加--139,517.96--1,882.6
存货的减少-758,240,342.27--1,145,375,047.35
经营性应收项目的减少-130,098,055.13-135,235,688.81
经营性应付项目的增加--153,011,337.12--211,804,447.51
其他-55,826,094.72--
现金的期末余额-1,991,274,292.13-875,264,962.72
减:现金的期初余额-875,264,962.72-601,235,578.96
加:现金等价物的期末余额-250,000,000-210,000,000
减:现金等价物的期初余额-210,000,000-230,000,000
公告日期2024-10-262024-08-272024-04-252024-04-18
审计意见(境内)标准无保留意见
TOP↑